A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. )
Clinical trial NCT03855306 · COMPLETED
Trial details
- NCT number
- NCT03855306
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-30
- Primary completion
- 2018-07-07
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.